Literature DB >> 10380819

The rationale for early diagnosis of cancer--the example of breast cancer.

M Tubiana1, S Koscielny.   

Abstract

The main advantage of early diagnosis of cancer is the reduction of tumor size at initial treatment and thereby an increase in the proportion of patients without distant dissemination. This benefit is illustrated by the example of breast cancer. A model of its natural history was built using data extracted from the files of over 4000 patients followed in the same institution for 20 to 35 years. The model was used to quantify the impact of tumor size, histologic grade, and lymph node involvement on the probability of distant spread. The relationships were found to be highly significant. The model also and unexpectedly revealed that the tumors progress while they grow; avoiding histologic progression is therefore another advantage of early diagnosis. The model showed that residual tumor can be a nidus for distant dissemination, and that consistency between the prediction of the model and the results of post-operative radiotherapy is satisfactory. Conversely to what is often stated, the benefits of post-operative radiotherapy appear to be greater for small tumors, even in the absence of lymph node involvement, than for large ones. The model could be used to help improve screening strategies, but more data are required, in particular for the young age range.

Entities:  

Mesh:

Year:  1999        PMID: 10380819     DOI: 10.1080/028418699431357

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Accuracy and Reliability of Infrared Thermography in Assessment of the Breasts of Women Affected by Cancer.

Authors:  Rinaldo Roberto de Jesus Guirro; Maíta Marade Oliveira Lima Leite Vaz; Lais Mara Siqueira das Neves; Almir Vieira Dibai-Filho; Hélio Humberto Angotti Carrara; Elaine Caldeira de Oliveira Guirro
Journal:  J Med Syst       Date:  2017-04-12       Impact factor: 4.460

2.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Machine Learning Algorithm for Distinguishing Ductal Carcinoma In Situ from Invasive Breast Cancer.

Authors:  Vu Pham Thao Vy; Melissa Min-Szu Yao; Nguyen Quoc Khanh Le; Wing P Chan
Journal:  Cancers (Basel)       Date:  2022-05-15       Impact factor: 6.575

4.  Preoperative selection of symptomatic breast cancer patients appropriate for lymphatic mapping and sentinel node biopsy.

Authors:  M Barry; R A Cahill; G Roche-Nagle; R Landers; D Walsh; D J Bouchier-Hayes; R G K Watson
Journal:  Ir J Med Sci       Date:  2007-05-03       Impact factor: 1.568

5.  Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

Authors:  Kelly A Metcalfe; William D Foulkes; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo A Olivotto; Ellen Warner; Olufunmilayo Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; Steven A Narod
Journal:  Hered Cancer Clin Pract       Date:  2005-04-15       Impact factor: 2.857

6.  The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.

Authors:  L M Privette Vinnedge; R McClaine; P K Wagh; K A Wikenheiser-Brokamp; S E Waltz; S I Wells
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

7.  The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.

Authors:  Victoria Sopik; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2018-04-24       Impact factor: 4.872

8.  Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data

Authors:  Ahmad Reza Baghestani; Parviz Shahmirzalou; Soheila Sayad; Mohammad Esmaeil Akbari; Farid Zayeri
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

9.  Risk of breast cancer based on thermal tomography characteristics.

Authors:  Si Sun; Xin Yu; Juanjuan Li; Zhiyu Li; Shan Zhu; Lijun Wang; Juan Wu; Kaiyang Li; Qi Wu; Shengrong Sun
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.